Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380047462> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4380047462 endingPage "943" @default.
- W4380047462 startingPage "937" @default.
- W4380047462 abstract "Purpose: To investigate how apigenin-7-glucoside (AGL) affects the proliferation, migration, invasion, and reactive oxygen species (ROS) accumulation in lung cancer cells, and to evaluate the potential of AGL as a therapeutic target.
 Methods: Human bronchial epithelial cells (BEAS-2B), human lung carcinoma (A549), and non-small cell lung cancer cells (H1975), were treated with 25, 50, 100, and 200 μM AGL. Cell viability curves and EdU assays were used to evaluate their proliferation, while apoptosis was assessed by flow cytometry. Cell migration and invasion were evaluated by Transwell assays, and western blot was performed to determine the expression level of cytochrome C and phosphorylation of PI3K, AKT, and mTOR. Furthermore, ELISA was used to quantify the level of malondialdehyde (MDA) and glutathione (GSH). Indirect immunofluorescent assay (IFA) was performed by staining with DCFH-DA to evaluate ROS level.
 Results: Proliferation of A549 and H1975 cells was suppressed by AGL in a dose-dependent manner. AGL significantly reduced proliferation, promoted cell apoptosis, and attenuated the migration and invasion of A549 or H1975 cells. It also elevated the levels of cytochrome C and MDA but reduced the production of GSH in A549 and H1975 cells. AGL enhanced the accumulation of ROS and weakened phosphorylation of AKT, PI3K, and mTOR in A549 and H1975 cells.
 Conclusion: AGL represses proliferation, promotes apoptosis, suppresses migration and invasion, and induces ROS accumulation in lung cancer cells by repressing PI3K/Akt/mTOR pathway, thus indicating the potential of AGL as a target in lung cancer treatment." @default.
- W4380047462 created "2023-06-10" @default.
- W4380047462 creator A5019516195 @default.
- W4380047462 creator A5063253432 @default.
- W4380047462 creator A5067183622 @default.
- W4380047462 creator A5075389451 @default.
- W4380047462 creator A5089119479 @default.
- W4380047462 date "2023-06-06" @default.
- W4380047462 modified "2023-09-30" @default.
- W4380047462 title "Apigenin-7-glucoside induces apoptosis and ROS accumulation in lung cancer cells, and inhibits PI3K/Akt/mTOR pathway" @default.
- W4380047462 doi "https://doi.org/10.4314/tjpr.v22i5.1" @default.
- W4380047462 hasPublicationYear "2023" @default.
- W4380047462 type Work @default.
- W4380047462 citedByCount "0" @default.
- W4380047462 crossrefType "journal-article" @default.
- W4380047462 hasAuthorship W4380047462A5019516195 @default.
- W4380047462 hasAuthorship W4380047462A5063253432 @default.
- W4380047462 hasAuthorship W4380047462A5067183622 @default.
- W4380047462 hasAuthorship W4380047462A5075389451 @default.
- W4380047462 hasAuthorship W4380047462A5089119479 @default.
- W4380047462 hasBestOaLocation W43800474621 @default.
- W4380047462 hasConcept C153911025 @default.
- W4380047462 hasConcept C185592680 @default.
- W4380047462 hasConcept C190283241 @default.
- W4380047462 hasConcept C2778004101 @default.
- W4380047462 hasConcept C2778609962 @default.
- W4380047462 hasConcept C2779054382 @default.
- W4380047462 hasConcept C48349386 @default.
- W4380047462 hasConcept C502942594 @default.
- W4380047462 hasConcept C53227056 @default.
- W4380047462 hasConcept C553184892 @default.
- W4380047462 hasConcept C55493867 @default.
- W4380047462 hasConcept C62112901 @default.
- W4380047462 hasConcept C75217442 @default.
- W4380047462 hasConcept C81729549 @default.
- W4380047462 hasConcept C86554907 @default.
- W4380047462 hasConcept C86803240 @default.
- W4380047462 hasConcept C95444343 @default.
- W4380047462 hasConceptScore W4380047462C153911025 @default.
- W4380047462 hasConceptScore W4380047462C185592680 @default.
- W4380047462 hasConceptScore W4380047462C190283241 @default.
- W4380047462 hasConceptScore W4380047462C2778004101 @default.
- W4380047462 hasConceptScore W4380047462C2778609962 @default.
- W4380047462 hasConceptScore W4380047462C2779054382 @default.
- W4380047462 hasConceptScore W4380047462C48349386 @default.
- W4380047462 hasConceptScore W4380047462C502942594 @default.
- W4380047462 hasConceptScore W4380047462C53227056 @default.
- W4380047462 hasConceptScore W4380047462C553184892 @default.
- W4380047462 hasConceptScore W4380047462C55493867 @default.
- W4380047462 hasConceptScore W4380047462C62112901 @default.
- W4380047462 hasConceptScore W4380047462C75217442 @default.
- W4380047462 hasConceptScore W4380047462C81729549 @default.
- W4380047462 hasConceptScore W4380047462C86554907 @default.
- W4380047462 hasConceptScore W4380047462C86803240 @default.
- W4380047462 hasConceptScore W4380047462C95444343 @default.
- W4380047462 hasIssue "5" @default.
- W4380047462 hasLocation W43800474621 @default.
- W4380047462 hasOpenAccess W4380047462 @default.
- W4380047462 hasPrimaryLocation W43800474621 @default.
- W4380047462 hasRelatedWork W2000231571 @default.
- W4380047462 hasRelatedWork W2348861186 @default.
- W4380047462 hasRelatedWork W2367461549 @default.
- W4380047462 hasRelatedWork W2378786766 @default.
- W4380047462 hasRelatedWork W2385169010 @default.
- W4380047462 hasRelatedWork W2385869791 @default.
- W4380047462 hasRelatedWork W2410520497 @default.
- W4380047462 hasRelatedWork W2954879943 @default.
- W4380047462 hasRelatedWork W2981184832 @default.
- W4380047462 hasRelatedWork W4288047318 @default.
- W4380047462 hasVolume "22" @default.
- W4380047462 isParatext "false" @default.
- W4380047462 isRetracted "false" @default.
- W4380047462 workType "article" @default.